Evidence map›Paper›PMID 37222136›Full record

ArticleEpidemiology and infection2023

Risk factors for acute toxoplasmosis in the Netherlands.

Ingrid H M Friesema, Agnetha Hofhuis, Denise Hoek-van Deursen, Arjan R Jansz, Alewijn Ott, Jaap J van Hellemond, Joke van der Giessen, Laetitia M Kortbeek, Marieke Opsteegh

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Epidemiology and infection, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Anti-Pathogens (Basel, Switzerland) · 2023
    Review
  7. Limited value of current and newFrontiers in parasitology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Ingrid H M FriesemaCentre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.ORCID 0000-0001-9943-0518
Agnetha HofhuisCentre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
Denise Hoek-van DeursenCentre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
Arjan R JanszDepartment of Medical Microbiology, Eurofins-PAMM, Veldhoven, The Netherlands.
Alewijn OttDepartment of Medical Microbiology, Certe, Groningen, The Netherlands.
Jaap J van HellemondDepartment of Medical Microbiology & Infectious Diseases, Erasmus MC University Medical Centre, Rotterdam, The Netherlands.
Joke van der GiessenCentre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
Laetitia M KortbeekCentre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
Marieke OpsteeghCentre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Toxoplasmosis caused by the protozoan parasite

Indexed as

ToxoplasmaToxoplasmosisCase-Control StudiesFemaleHumansNetherlandsPregnancyRisk FactorsCase-control studyrisk factorsToxoplasma gondiitoxoplasmosis

Identifiers

PMID37222136
PMCPMC10311679

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.